RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Financials
  4. Diluted EPS

GILEAD SCIENCES, INC.GILD

Market cap
$157.1B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 20240.4-91.56%
Dec 31, 20234.5+23.63%
Dec 31, 20223.6-26.17%
Dec 31, 20214.9+4830.00%
Dec 31, 20200.1-97.63%
Dec 31, 20194.2+1.20%
Dec 31, 20184.2+18.80%
Dec 31, 20173.5-64.69%
Dec 31, 20169.9-16.54%
Dec 31, 201511.9+62.04%
Dec 31, 20147.4+306.08%
Dec 31, 20131.8+10.37%
Dec 31, 20121.6-53.80%
Dec 31, 20113.6+6.93%
Dec 31, 20103.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)